DE69407807T2 - Indolin verbindungen und sie als aktivbestandteil enthaltende 5-ht3-antagonisten - Google Patents

Indolin verbindungen und sie als aktivbestandteil enthaltende 5-ht3-antagonisten

Info

Publication number
DE69407807T2
DE69407807T2 DE69407807T DE69407807T DE69407807T2 DE 69407807 T2 DE69407807 T2 DE 69407807T2 DE 69407807 T DE69407807 T DE 69407807T DE 69407807 T DE69407807 T DE 69407807T DE 69407807 T2 DE69407807 T2 DE 69407807T2
Authority
DE
Germany
Prior art keywords
group
chem
receptor antagonists
indolin
connections
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69407807T
Other languages
English (en)
Other versions
DE69407807D1 (de
Inventor
Shinji Tokyo Tanabe C Tsuchiya
Nobuyuki Tokyo Tanabe C Yasuda
Atsushi Tokyo Tanabe Fukuzaki
Koichi Tokyo Tanabe Com Kazama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Tokyo Pharmaceuticals Inc
Original Assignee
Tokyo Tanabe Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tokyo Tanabe Co Ltd filed Critical Tokyo Tanabe Co Ltd
Priority claimed from PCT/JP1994/001641 external-priority patent/WO1995009168A1/ja
Application granted granted Critical
Publication of DE69407807D1 publication Critical patent/DE69407807D1/de
Publication of DE69407807T2 publication Critical patent/DE69407807T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
DE69407807T 1993-09-30 1994-09-30 Indolin verbindungen und sie als aktivbestandteil enthaltende 5-ht3-antagonisten Expired - Fee Related DE69407807T2 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP24577893 1993-09-30
JP6272894 1994-03-31
PCT/JP1994/001622 WO1995009167A1 (fr) 1993-09-30 1994-09-29 Derive d'indoline et antagoniste du recepteur 5-ht3 contenant ce derive et utilise comme ingredient actif
PCT/JP1994/001641 WO1995009168A1 (fr) 1993-09-30 1994-09-30 Compose d'indoline et antagoniste des recepteurs de 5-ht3 contenant ce compose comme principe actif

Publications (2)

Publication Number Publication Date
DE69407807D1 DE69407807D1 (de) 1998-02-12
DE69407807T2 true DE69407807T2 (de) 1998-05-20

Family

ID=26403780

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69407807T Expired - Fee Related DE69407807T2 (de) 1993-09-30 1994-09-30 Indolin verbindungen und sie als aktivbestandteil enthaltende 5-ht3-antagonisten

Country Status (8)

Country Link
US (1) US5677326A (de)
EP (1) EP0721949B1 (de)
KR (1) KR960704881A (de)
AT (1) ATE161842T1 (de)
AU (2) AU7707994A (de)
CA (1) CA2173155A1 (de)
DE (1) DE69407807T2 (de)
WO (1) WO1995009167A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5521183A (en) * 1994-08-30 1996-05-28 Allergan Use of 5-HT ligands as anti-pruritic agents
US5936098A (en) * 1995-02-17 1999-08-10 Tokyo Tanabe Company Limited Process for producing indoline compounds and intermediates for the production of the same
WO1996025396A1 (fr) * 1995-02-17 1996-08-22 Tokyo Tanabe Company Limited Procede de preparation de composes indoline et intermediaires de cette preparation
US6562629B1 (en) 1999-08-11 2003-05-13 Cedars-Sinai Medical Center Method of diagnosing irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth by detecting the presence of anti-saccharomyces cerivisiae antibodies (asca) in human serum
US7048906B2 (en) 1995-05-17 2006-05-23 Cedars-Sinai Medical Center Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
US6861053B1 (en) * 1999-08-11 2005-03-01 Cedars-Sinai Medical Center Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
FR2744452B1 (fr) * 1996-02-06 1998-03-06 Cird Galderma Composes biaryles heterocycliques, compositions pharmaceutiques et cosmetiques les contenant et utilisations
US6437147B1 (en) 2000-03-17 2002-08-20 Novo Nordisk Imidazole compounds
WO2001068652A1 (en) * 2000-03-17 2001-09-20 Novo Nordisk A/S Condensed imidazoles as histamine h3 receptor ligands
BR0317606A (pt) * 2002-12-20 2005-11-29 Dynogen Pharmaceuticals Inc Métodos de tratamento de distúrbios não dolorosos da bexiga urinária que usam moduladores de canal de cálcio de subunidade (alfa)2(delta)
EP1492519B1 (de) * 2003-03-21 2006-11-15 Dynogen Pharmaceuticals, Inc. Verfahren zur behandlung von erkrankungen der unteren harnwege mit antimuskarinika und mit modulatoren der alpha-2-delta untereinheit des kalziumkanals
ES2432618T3 (es) 2009-05-20 2013-12-04 Inserm (Institut National De La Santé Et De La Recherche Medicale) Antagonistas del receptor 5-HT3 de serotonina para usar en el tratamiento o prevención de una patología del oído interno con déficit vestibular
US8580730B2 (en) 2009-05-20 2013-11-12 (Inserm) Institut National De La Sante Et De La Recherche Medicale Methods of treating lesional vestibular disorders by administering serotonin 5-HT3 receptor antagonists

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3401173A (en) * 1966-04-05 1968-09-10 Smith Kline French Lab Heterocyclic acylaminobenzimidazoles
CH528514A (de) * 1969-05-22 1972-09-30 Bayer Ag Verfahren zur Herstellung von Acylimidazolen
US4080330A (en) * 1975-06-23 1978-03-21 Delmar Chemicals Limited Phenylindolines and process for their production
SU786266A1 (ru) * 1978-12-04 1982-05-07 Ростовский Ордена Трудового Красного Знамени Государственный Университет Способ получени 2-бензимидазолиларилкетонов
DE3708292A1 (de) * 1987-03-14 1988-09-29 Basf Ag Gegen einwirkung von licht stabilisierte polymere sowie neue imidazol-2-carbonsaeureanilide
ATE144511T1 (de) * 1989-02-02 1996-11-15 Yamanouchi Pharma Co Ltd Tetrahydrobenzimidazol-derivate
US5344927A (en) * 1989-02-02 1994-09-06 Yamanouchi Pharmaceutical Co., Ltd. Tetrahydrobenzimidazole derivatives and pharmaceutical compositions containing same

Also Published As

Publication number Publication date
US5677326A (en) 1997-10-14
EP0721949A4 (de) 1996-08-28
EP0721949B1 (de) 1998-01-07
CA2173155A1 (en) 1995-04-06
EP0721949A1 (de) 1996-07-17
DE69407807D1 (de) 1998-02-12
WO1995009167A1 (fr) 1995-04-06
KR960704881A (ko) 1996-10-09
ATE161842T1 (de) 1998-01-15
AU7708394A (en) 1995-04-18
AU678057B2 (en) 1997-05-15
AU7707994A (en) 1995-04-18

Similar Documents

Publication Publication Date Title
DE69407807D1 (de) Indolin verbindungen und sie als aktivbestandteil enthaltende 5-ht3-antagonisten
ATE206412T1 (de) Heterocyclische verbindungen als bradykinin antagonisten
DE69011318T2 (de) Diazinderivate als Angiotensin II Rezeptor Antagonisten.
TR199801211T2 (xx) Takikinin resept�r antagonistleri olarak 1-(1,2-�ift-ikameli piperidinil ) -4-ikameli piperidin t�revleri.
UA27238C2 (uk) Індолінові похідні, а також їх фармацевтично прийнятні солі, що є антагоністами вазопресинових v1-рецепторів, спосіб їх одержання, проміжні продукти і фармацевтична композиція
TR200100698T2 (tr) 5-HT4 alıcı-Antagonistleri olarak Dihidrobenzodioksin Karboksamit ve Keton türevleri
HK1070054A1 (en) Arylsulfonyl derivatives with5-ht6 receptor affinity
DK0862562T3 (da) Benzoxazepinforbindelser, fremstilling deraf og anvendelse deraf som lipidniveauformindskende midler
IE840182L (en) Des-proline vasopressin antagonists
ATE148704T1 (de) Imidazo (1,2-a> pyrasin-4-on-derivate welche als ampa und nmda receptor antagonisten dienen
DE69022744T2 (de) Piperidin und pyrrolidin derivate.
TR200101711T2 (tr) Antihistaminik spiro bileşikler.
PE20050442A1 (es) Derivados de 8-azoniabiciclo[3.2.1]octano como antagonistas de receptores muscarinicos de la acetilcolina
EP0725068A4 (de) Indolderivate
NO961797L (no) Anvendelse av benzopyranderivater for fremstilling av farmasöytiske sammensetninger beregnet for behandling av patologier forbundet med den Na+-uavhengige C1-HCO3-utbytter
ATE170851T1 (de) Guanidinothiazolederivate und ihre anwendung als h2-rezeptor-antagonisten
GB9720270D0 (en) Medicaments for the treatment of migraine
TR200003858T2 (tr) 4,5,6 ve D-indol ve indolin türevlerinin kullanımı.
GB8308601D0 (en) Heterocyclic compounds
DE69217148D1 (de) Isoxazole derivate als lichtschutzmittel
EP0878475A3 (de) 5-(4-Piperidinyl)dibenzothiazepine derivate und 5-(4-piperidinyl)dibenzoxazepinderivate, und antiarrhythmische Mittel
YU28701A (sh) N-(2-(heteroaril)etil)-3-fenilpiperidini, n-(2-(heteroaril) etil)-4-fenilpiperidin i srodna jedinjenja sa supstituentom u položaju 4 piperidinskog prstena
TR199801735A2 (xx) 2-(arilfenil)amino-imidazolin türevleri.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: MITSUBISHI-TOKYO PHARMACEUTICALS, INC., TOKIO, JP

8339 Ceased/non-payment of the annual fee